Exploring Cancer Drugs as Potential Alzheimer’s Therapies

Researchers are exploring the potential of repurposing cancer drugs, specifically letrozole and irinotecan, to treat Alzheimer's disease. A study identified these drugs as promising candidates that may slow or reverse symptoms in mice by altering gene expression related to the disease. While initial results are encouraging, further clinical trials are needed to assess safety and effectiveness in humans, considering the significant side effects of these drugs.